Search results for: 'mega fuels develop deceleration'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) comprises insights across new developments for antibody-drug conjugates, T-cell engagers, cell and gene therapies, precision immunology and cancer care.The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life science...

The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

This research looks at the state of firmware security and the impact of firmware security on the overall IoT security market. The research identifies firmware development process within organizations and focuses on the companies that have developed innovative platforms and solutions to secure firmware at each stage of development, system integratio...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in targeted therapies for cancer, immunological and inflammatory diseases. The research also covers technological developments across vaccines, neuroprotective medicines, cell therapies, monoclonal antibody and oncolytic virus platform...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments in female contraception technique, small molecule drugs, cell and gene therapies, cancer diagnosis and treatment and nanobody technologies. The research also encompasses emerging innovations across infectious and immu...

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion models, and structure-based models are expanding the u...

The global oil and gas PPE market generated a revenue of $6.3 billion in 2018 and is expected to grow at a CARG of 3.7% between 2018 and 2023. Protective clothing, protective footwear, and gas protection are the major product segments; they accounted for 25.5%, 25.3%, and 11.8%, respectively, and are set to see the highest growth. North America, ...

30 Apr 2020  |  North America  |  Market Outlook

Global Autonomous Driving Industry Outlook, 2020

OEMs are Reprioritizing Short-term Economic Returns on Investments into Autonomous Driving (AD) by Adopting L2+ Technologies and Investing in Plug-and-play Platforms

Infographics

×

Key Issues Addressed

The autonomous industry, although developing at a decent pace, has realized that the transition from traditional vehicles to autonomous vehicles is still a long time away. OEMs and Tier-1 suppliers have been pouring in investments to develop technologies for deployments of highly automated vehicles. However, despite overcoming the technological bar...